Clin Infect Dis. 1994 Oct;19(4):774-6. Unique Identifier : AIDSLINE
We describe three men with disseminated, drug-sensitive tuberculosis and
advanced human immunodeficiency virus disease (CD4+ lymphocyte count, <
50/mm3) who had flares of tuberculous lymphadenitis with suppuration
during the initial weeks of successful chemotherapy. Bactericidal drugs
may kindle these transient exacerbations, which involve neutrophils but
apparently do not require normal helper T cell function. In patients
with AIDS, as in immunocompetent individuals, treatment-related flares
of lymphadenitis are usually not an adverse sign, provided that drug
resistance and nonadherence have been excluded.
Adult Antitubercular Agents/*THERAPEUTIC USE AIDS-Related
Opportunistic Infections/*DRUG THERAPY/IMMUNOLOGY Case Report
Ethambutol/THERAPEUTIC USE Human Isoniazid/THERAPEUTIC USE Leukocyte
Count Male Pyrazinamide/THERAPEUTIC USE Rifampin/THERAPEUTIC USE
Tuberculosis, Lymph Node/*DRUG THERAPY/IMMUNOLOGY Tuberculosis,
Multidrug-Resistant/*DRUG THERAPY/IMMUNOLOGY JOURNAL ARTICLE